Market Research Logo

Global Precision Medicine IT Solutions for Oncology—Companies to Action, 2017

Global Precision Medicine IT Solutions for Oncology—Companies to Action, 2017


Precision medicine for oncology is defined as patient-specific cancer care that is aided by a targeted software suite. The realm of precision medicine is determined by providers' willingness and ability to capture and normalize disparate patient data - including clinical, socioeconomic, behavioral, and genomic - to identify evidence-based treatments that are ideal for each patient.

Report Outlook

This report profiles vendors that are offering promising, disruptive, and pioneering solutions across diverse domains in precision medicine for oncology. It brings the most recent and successful and/or high-potential companies to light. The focus has been to identify vendors that bring in the advantage purely in terms of analytics - not other components of data management and meaningful use. These companies create extraordinary value for their internal and external stakeholders by showcasing visionary leadership and implementing industry best practices, and through business model innovation.

Market Snapshot

Healthcare IT ecosystems around the world are not adequately equipped to facilitate seamless data interoperability across the care continuum, which is fundamental for enabling precision medicine. For example, even in the United States - arguably a progressive and technologically sophisticated digital health market - the regulatory framework (e.g., CMS, ONC, HHS*) fails to introduce clear mandates that safeguard the privacy of patients willing to share medical data for the Precision Medicine Initiative; outline incentive guidelines for patients accepting precision medicine approaches; introduce reimbursement programs for providers investing in precision medicine systems; and encourage consideration of patients‘ sociobehavioral state to adjust treatment pathways. As a result, most providers have yet to realize tangible ROIs from precision medicine pilots.
Poor support from ecosystem-level partners (incumbent EHR, RCM, HIE, and clinical decision support system vendors) coupled with a lack of ROI evidence validates that the precision medicine market is still in its infancy.

Despite the low levels of supply-side maturity, more providers will embrace precision medicine, especially in the United States, to improve patient outcomes and rationalize corporate profitability due to mandatory or voluntary involvement in value-based care and the Precision Medicine Initiative. They will depend on external specialist firms to develop proprietary tools or introduce third-party platforms.

Precision medicine IT vendors are going to leverage this renewed market interest to facilitate visionary patient services, supported by the latest clinical and academic evidence.

Key Takeaway

Top vendors will digitize and automate the process of patient data capture, analysis, and reporting. They will help generate patient-specific treatment options and recommend potential recovery plans based on each patient‘s clinical and genomic profiles. Physicians will be able to validate these auto-generated clinical pathways based on their experience and knowledge.

  • Methodology
  • Scope and Segmentation
  • Executive Summary
    • Global Precision Medicine IT Market Snapshot
    • Global Precision Medicine IT Solutions for Oncology- Analysis of Companies to Action
    • Strategic Imperatives for Industry Stakeholders to Explore Precision Medicine
    • Precision Medicine-Regional Market Overview
    • Key Questions this Study will Answer
    • Precision Medicine-Future Impact on Healthcare
    • Precision Medicine-Strategic Imperatives for Success and Growth
  • Companies to Action Overview
    • Industry Convergence Driving Disruption and Innovation
    • Convergence in Healthcare Creates Both Opportunities and Threats
    • Frost & Sullivan Companies to Action Have the Potential to Disrupt Current Healthcare Industry Paradigms
  • Digital Health Industry Snapshot
    • Digital Health Benefits from Broader Industry Convergence
    • Digital Health Priorities
    • Digital Health Market Segmentation and Convergence
  • Precision Medicine for Oncology Market Overview
    • What is Precision Medicine?
    • Market Challenges, Opportunities, and Concerns
    • Current State of Precision Medicine Adoption
    • Key Data Sources for Precision Medicine
    • Impact of Precision Medicine on Oncology
    • Impact of Key Market Influencers
    • Operational Architecture of Precision Medicine for Oncology
    • Operational Architecture of Precision Medicine for Oncology Explained
    • Stakeholders' Digital Health Solutions
    • Digital Health Solutions Applicable Across the Care Continuum
    • Digital Health Companies Supporting Precision Medicine for Oncology-Vendor Landscape
    • Digital Health Companies Supporting Precision Medicine for Oncology-Vendor Landscape Discussion
    • Top Industry Needs and Vendor Strategies
    • Precision Medicine IT Solutions for Oncology-C2A Key Findings
  • C2A Profiles
    • 2bPrecise (Allscripts)
    • Cerner
    • GenomOncology
    • IBM Watson Health
    • N-of-One
    • NantHealth
    • Navican (an Intermountain Healthcare Company)
    • Quest Diagnostics
    • Royal Philips
    • Via Oncology
  • The Last Word
    • Precision Medicine-Future Impact on Healthcare
    • Precision Medicine-Strategic Imperatives for Success and Growth
  • Appendix
    • List of Vendors Assessed
    • Abbreviation List

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report